Physician profile
Mark W Sheldon
NPI 1568425726
$2,073.38
in general payments reported to CMS, 2019-2025
15 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $242 · 2021: $176 · 2022: $243 · 2023: $594 · 2024: $430 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,125.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $479.98 | 2019-2025 | Watchman Flx, Watchman, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $300.91 | 2020-2023 | Camzyos |
| Medtronic Vascular, INC. | $183.75 | 2019 | |
| Abiomed | $170.48 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $154.86 | 2019-2024 | |
| Abbott Laboratories | $153.30 | 2022-2023 | Diamondback Coronary, Optis |
| Janssen Pharmaceuticals, INC | $119.97 | 2024 | Xarelto |
| Cardiovascular Systems INC. | $106.82 | 2020-2023 | Diamondback Coronary |
| Cvrx, INC. | $105.77 | 2023 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.19 | 2019-2020 | |
| Shockwave Medical, INC | $75.86 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $51.94 | 2021-2024 | Onyx Frontier, Symplicity G3 |
| Biosense Webster, INC. | $47.05 | 2021-2025 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $18.13 | 2019 | |
| W. L. Gore & Associates, INC. | $16.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Sheldon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.